Anti-cTnT MAbs with Negligible Cross-Reactivity to Skeletal Troponin T

Published: 30.05.2018

In high-sensitivity troponin assays, the specificity of the antibodies utilized is of utmost importance. As the clinically relevant concentration of cardiac troponin T is just nanograms per litre, even a minor cross-reactivity of the assay to skeletal troponin T isoforms could result in false positives. This was recently proved in a study of patients with skeletal myopathies (Schmid et al., 2018).

We have recently developed three new anti-cTnT MAbs (300cc, 329cc and 406cc, Cat.# 4T19cc) and showed that the prototype assays utilizing these MAbs demonstrate a good correlation with the commercially available hs-cTnT assay. Using purified recombinant skeletal TnT proteins we now show that the MAbs demonstrate negligible cross-reactivity to both fast and slow isoforms of skTnT.

First, individual MAbs were incubated with purified native cTnT and a mixture of recombinant slow and fast skTnT proteins. All three MAbs recognized only cTnT (see Figure 1). Second, we tested the cross-reactivity of the two prototype assays to purified native skTnT, recombinant fast skTnT and recombinant slow skTnT. Also in this case the cross-reactivity was well below 0.1% (see Figure 2).

Figure 1: 50 ng of cTnT or a mixture of two skeletal isoforms (1:1; slow and fast skTnT) was coated on microtiter plate wells. Primary MAb was anti-cTnT as denoted in the picture. Secondary antibody was HRP-conjugated goat anti-mouse polyclonal antibody. Substrate: TMB.


Figure 2: We tested the cross-reactivity of two prototype assays to several biomarkers including fast and slow skeletal TnT and purified native skTnT. The results show that both assays show negligible cross-reactivity to all markers tested. In hs-cTnT immunoassays the cross-reactivity should be < 0.10 % and preferably < 0.05-0.03 %.IGFBP-4 and MPO were used as negative controls.

Cat# 4T19cc: cTnT, human, antibody, in vitro
Cat# 8RFT4: Recombinant human fast skeletal troponin T (fast skTnT)
Cat# 8RST2: Recombinant human slow skeletal troponin T (slow skTnT)
All cTnT and other cardiac marker related products

Cardiac troponin T (cTnT) TechNotes

Schmid, J. et al. Elevated Cardiac Troponin T in Patients With Skeletal Myopathies. Journal of the American College of Cardiology 71, 1540–1549 (2018).

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!